Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 706

    1.

    Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy.

    Lai TY, Chan WM, Liu DT, Luk FO, Lam DS.

    Br J Ophthalmol. 2008 May;92(5):661-6. Epub 2008 Mar 20.PMID: 18356265 [PubMed - indexed for MEDLINE]Related articles

    2.

    The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy.

    Lee SY, Kim JG, Joe SG, Chung H, Yoon YH.

    Korean J Ophthalmol. 2008 Jun;22(2):92-9.PMID: 18612226 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.
    4.

    Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

    Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. Epub 2007 Feb 28.PMID: 17333238 [PubMed - indexed for MEDLINE]Related articles

    5.

    Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

    Chan WM, Lam DS, Lai TY, Liu DT, Li KK, Yao Y, Wong TH.

    Ophthalmology. 2004 Aug;111(8):1576-84.PMID: 15288991 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.

    Smith BT, Dhalla MS, Shah GK, Blinder KJ, Ryan EH Jr, Mittra RA.

    Retina. 2008 May;28(5):675-81.PMID: 18463509 [PubMed - indexed for MEDLINE]Related articles

    7.

    Intravitreal bevacizumab vs verteporfin photodynamic therapy for neovascular age-related macular degeneration.

    Bashshur ZF, Schakal A, Hamam RN, El Haibi CP, Jaafar RF, Noureddin BN.

    Arch Ophthalmol. 2007 Oct;125(10):1357-61.PMID: 17923543 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.

    Kaiser PK; Registry of Visudyne AMD Therapy Writing Committee, Boyer DS, Garcia R, Hao Y, Hughes MS, Jabbour NM, Kaiser PK, Mieler W, Slakter JS, Samuel M, Tolentino MJ, Roth D, Sheidow T, Strong HA.

    Ophthalmology. 2009 Apr;116(4):747-55, 755.e1. Epub 2009 Feb 25.PMID: 19243834 [PubMed - indexed for MEDLINE]Related articles

    9.

    Single-session photodynamic therapy combined with intravitreal bevacizumab for retinal angiomatous proliferation.

    Lo Giudice G, Gismondi M, De Belvis V, Cian R, Tavolato M, Galan A.

    Retina. 2009 Jul-Aug;29(7):949-55.PMID: 19584653 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.

    Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I.

    Retina. 2007 Sep;27(7):891-6.PMID: 17891013 [PubMed - indexed for MEDLINE]Related articles

    11.

    Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.

    Chan WM, Lai TY, Liu DT, Lam DS.

    Ophthalmology. 2007 Dec;114(12):2190-6. Epub 2007 Jun 28.PMID: 17599414 [PubMed - indexed for MEDLINE]Related articles

    12.

    Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.

    Dhalla MS, Shah GK, Blinder KJ, Ryan EH Jr, Mittra RA, Tewari A.

    Retina. 2006 Nov-Dec;26(9):988-93.PMID: 17151484 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

    Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

    14.

    Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation.

    Saito M, Shiragami C, Shiraga F, Nagayama D, Iida T.

    Am J Ophthalmol. 2008 Dec;146(6):935-41.e1. Epub 2008 Aug 23.PMID: 18723139 [PubMed - indexed for MEDLINE]Related articles

    15.

    Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy.

    Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Oshima Y, Kamei M, Tano Y.

    Br J Ophthalmol. 2008 Jan;92(1):70-3. Epub 2007 Jun 13.PMID: 17567661 [PubMed - indexed for MEDLINE]Related articles

    16.

    Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy.

    Mauget-Faÿsse M, Quaranta-El Maftouhi M, De La Marnièrre E, Leys A.

    Eur J Ophthalmol. 2006 Sep-Oct;16(5):695-704.PMID: 17061220 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum.

    Finger RP, Charbel Issa P, Ladewig M, Holz FG, Scholl HP.

    Br J Ophthalmol. 2008 Apr;92(4):483-7.PMID: 18369065 [PubMed - indexed for MEDLINE]Related articles

    18.

    The therapeutic effects of intravitreal bevacizumab in a patient with recalcitrant idiopathic polypoidal choroidal vasculopathy.

    Ghajarnia M, Kurup S, Eller A.

    Semin Ophthalmol. 2007 Apr-Jun;22(2):127-31.PMID: 17564935 [PubMed - indexed for MEDLINE]Related articles

    19.

    Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula.

    Lee SC, Seong YS, Kim SS, Koh HJ, Kwon OW.

    Ophthalmologica. 2004 May-Jun;218(3):193-201.PMID: 15103216 [PubMed - indexed for MEDLINE]Related articles

    20.

    Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.

    Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U.

    Br J Ophthalmol. 2008 Mar;92(3):356-60.PMID: 18303156 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data